المؤلفون: Spence, Sebastian

مصطلحات موضوعية: Superfluid, Nanofluidics, optomechanics, Microwave, HE-4, sonic crystal, phononic

الوصول الحر: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.865211Test

المؤلفون: Samican Özmen, Sefa Kurt, Orkun Ilgen, Funda Barlik Obuz, Ali Riza Sisman, Meral Koyuncuoglu

المصدر: Journal of Clinical and Investigative Surgery, Vol 6, Iss 1, Pp 22-29 (2021)

مصطلحات موضوعية: endometrial cancer, magnetic resonance imaging, he-4, ca-125, Medicine

وصف الملف: electronic resource

العلاقة: https://www.e-repository.org/jcis/6/1/5.pdfTest; https://doaj.org/toc/2559-5555Test

الوصول الحر: https://doaj.org/article/54fe96db1dfd461b8e0cc8131486d922Test

المؤلفون: Searfus, Oskar

مصطلحات موضوعية: fast neutrons, neutron detection, nuclear security, nuclear safeguards, He-4, Nuclear Engineering and Radiological Sciences, Physics, Engineering, Science

الإتاحة: https://doi.org/10.7302/22935Test
http://deepblue.lib.umich.edu/handle/2027.42/193290Test

المؤلفون: О. М. Сухіна, К. В. Немальцова, В. С. Сухін

المصدر: Український радіологічний та онкологічний журнал, Vol 28, Iss 4, Pp 364-373 (2020)

مصطلحات موضوعية: malignant tumors of the ovaries, relapse, tumor-associated markers, he-4, ca-125., Medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://ukroj.com/index.php/journal/article/view/55Test; https://doaj.org/toc/2708-7166Test; https://doaj.org/toc/2708-7174Test

الوصول الحر: https://doaj.org/article/3ad17722179944d1aac28e4f8f6db414Test

المؤلفون: Institute for Safety Problems of Nuclear Power Plants

مصطلحات موضوعية: NPP, isotope hydrology, H-3, C-14, C-13, O-18, Sr-90, He-3, He-4

العلاقة: https://zenodo.org/record/6660132Test; https://doi.org/10.5281/zenodo.6660132Test; oai:zenodo.org:6660132

الإتاحة: https://doi.org/10.5281/zenodo.6660132Test
https://doi.org/10.5281/zenodo.6660131Test
https://zenodo.org/record/6660132Test

المؤلفون: Jain, Shruti, Nadeem, Nimrah, Ulfenborg, Benjamin, Mäkelä, Maria, Ruma, Shamima Afrin, Terävä, Joonas, Huhtinen, Kaisa, Leivo, Janne, Kristjansdottir, Björg, Pettersson, Kim, Sundfeldt, Karin, Gidwani, Kamlesh

المساهمون: Research Program in Systems Oncology, Faculty of Medicine

مصطلحات موضوعية: diagnosis, epithelial ovarian cancer, europium nanoparticle, mucins, STn, PROTEIN GLYCOSYLATION, BIOMARKERS, CA125, EXPRESSION, GLYCANS, HE-4, TN, 3111 Biomedicine, 3122 Cancers

وصف الملف: application/pdf

العلاقة: ALF-VGR Region, Sweden, Grant/Award Numbers: ALFGBG-721051, ALFGBG932583; Jane ja Aatos Erkon Saatio; Nordic Cancer Union, Denmark, Grant/Award Number: 194914; Swedish Cancer Foundation, Grant/Award Number: CAN-2018/834; Jain , S , Nadeem , N , Ulfenborg , B , Mäkelä , M , Ruma , S A , Terävä , J , Huhtinen , K , Leivo , J , Kristjansdottir , B , Pettersson , K , Sundfeldt , K & Gidwani , K 2022 , ' Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer ' , International Journal of Cancer , vol. 151 , no. 7 , pp. 1175-1184 . https://doi.org/10.1002/ijc.34111Test; ORCID: /0000-0001-9685-5246/work/117949806; 174b9933-c19f-43fb-93c9-8830d67b7231; http://hdl.handle.net/10138/347487Test; 000799910200001

الإتاحة: http://hdl.handle.net/10138/347487Test

المؤلفون: Savarese, Gianluigi, Uijl, Alicia, Ouwerkerk, Wouter, Tromp, Jasper, Anker, Stefan D., Dickstein, Kenneth, Hage, Camilla, Lam, Carolyn S. P., Lang, Chim C., Metra, Marco, Ng, Leong L., Orsini, Nicola, Samani, Nilesh J., Veldhuisen, Dirk J., Cleland, John G. F., Voors, Adriaan A., Lund, Lars H.

المصدر: Savarese , G , Uijl , A , Ouwerkerk , W , Tromp , J , Anker , S D , Dickstein , K , Hage , C , Lam , C S P , Lang , C C , Metra , M , Ng , L L , Orsini , N , Samani , N J , Veldhuisen , D J , Cleland , J G F , Voors , A A & Lund , L H 2022 , ' Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction ' , ESC ....

مصطلحات موضوعية: Biomarkers, Surrogate endpoint, Surrogate outcome, Heart failure with reduced ejection fraction, Phase 2, Randomized trial, NATRIURETIC PEPTIDE, EUROPEAN-SOCIETY, MORTALITY, ASSOCIATION, HE-4, HOSPITALIZATION, INHIBITION, VALIDATION, DIAGNOSIS, PROTEIN

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/a937f71e-210f-4817-aab0-7a4b96cc3202Test

الإتاحة: https://doi.org/10.1002/ehf2.13917Test
https://hdl.handle.net/11370/a937f71e-210f-4817-aab0-7a4b96cc3202Test
https://research.rug.nl/en/publications/a937f71e-210f-4817-aab0-7a4b96cc3202Test
https://pure.rug.nl/ws/files/219399704/ESC_Heart_Failure_2022_Savarese_Biomarker_changes_as_surrogate_endpoints_in_early_phase_trials_in_heart_failure_with.pdfTest

المؤلفون: Hulstaert, Eva, Levanon, Keren, Morlion, Annelien, Van Aelst, Stefan, Christidis, Anthony-Alexander, Zamar, Ruben, Anckaert, Jasper, Verniers, Kimberly, Bahar-Shany, Keren, Sapoznik, Stav, Vandesompele, Jo, Mestdagh, Pieter

المصدر: NEOPLASIA ; ISSN: 1476-5586

مصطلحات موضوعية: Medicine and Health Sciences, Cancer Research, Ovarian cancer, Utero-tubal lavage, Biomarker, Cell-free RNA, Liquid biopsy, VARIABLE SELECTION, RISK, REGULARIZATION, EXPRESSION, ALGORITHM, MORTALITY, CA125, HE-4

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/8740895Test; http://hdl.handle.net/1854/LU-8740895Test; http://dx.doi.org/10.1016/j.neo.2021.12.008Test; https://biblio.ugent.be/publication/8740895/file/8740953Test

الإتاحة: https://doi.org/10.1016/j.neo.2021.12.008Test
https://biblio.ugent.be/publication/8740895Test
http://hdl.handle.net/1854/LU-8740895Test
https://biblio.ugent.be/publication/8740895/file/8740953Test

المؤلفون: Davenport, Clare F, Rai, Nirmala, Sharma, Pawana, Deeks, Jon, Berhane, Sarah, Mallett, Sue, Saha, Pratyusha, Solanki, Rita, Bayliss, Susan, Snell, Kym, Sundar, Sudha

المصدر: Cancers , 14 (15) , Article 3621. (2022)

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Oncology, ovarian cancer, RMI, ROMA, ADNEX, diagnostic test accuracy, MALIGNANCY ALGORITHM ROMA, EPIDIDYMIS PROTEIN 4, EXTERNAL VALIDATION, RISK, HE-4, ACCURACY, CA125, PREDICTION, INDEX, SPECIFICITY

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10155075/1/Mallet_Diagnostic%20Models%20Combining%20Clinical%20Information,%20Ultrasound%20and%20Biochemical%20Markers%20for%20Ovarian%20Cancer_VoR.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10155075Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10155075/1/Mallet_Diagnostic%20Models%20Combining%20Clinical%20Information,%20Ultrasound%20and%20Biochemical%20Markers%20for%20Ovarian%20Cancer_VoR.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10155075Test/

المؤلفون: E. Frantsiyants M., T. Moiseenko I., D. Yakubova Yu., N. Cheryarina D., A. Menshenina P., E. Verenikina V., M. Adamyan L., Е. Франциянц М., Т. Моисеенко И., Д. Якубова Ю., Н. Черярина Д., А. Меньшенина П., Е. Вереникина В., М. Адамян Л.

المصدر: Siberian journal of oncology; Том 20, № 6 (2021); 69-77 ; Сибирский онкологический журнал; Том 20, № 6 (2021); 69-77 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2021-20-6

مصطلحات موضوعية: ovarian cancer, polychemotherapy, He-4 protein, VegF-a, cytostatic therapy, platinum resistance of ovarian cancer, рак яичников, онкобелок Не-4, химиотерапия, платиночувствительность

وصف الملف: application/pdf

العلاقة: https://www.siboncoj.ru/jour/article/view/1988/932Test; Zhang L.Y., Chen Y., Jia J., Zhu X., He Y., Wu L.M. MiR-27a promotes EMT in ovarian cancer through active Wnt/β-catenin signalling by targeting FOXO1. Cancer Biomark. 2019; 24(1): 31–42. doi:10.3233/CBM-181229.; James N.E., Chichester C., Ribeiro J.R. Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. Front Oncol. 2018 Apr 24; 8: 124. doi:10.3389/fonc.2018.00124.; Vaughan S., Coward J.I., Bast R.C.Jr., Berchuck A., Berek J.S., Brenton J.D., Coukos G., Crum C.C., Drapkin R., Etemadmoghadam D., Friedlander M., Gabra H., Kaye S.B., Lord C.J., Lengyel E., Levine D.A., McNeish I.A., Menon U., Mills G.B., Nephew K.P., Oza A.M., Sood A.K., Stronach E.A., Walczak H., Bowtell D.D., Balkwill F.R. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011 Sep 23; 11(10): 719–25. doi:10.1038/nrc3144.; Gomes A.M., Carron E.C., Mills K.L., Dow A.M., Gray Z., Fecca C.R., Lakey M.A., Carmeliet P., Kittrell F., Medina D., Machado H.L. Stromal Gas6 promotes the progression of premalignant mammary cells. Oncogene. 2019 Apr; 38(14): 2437–2450. doi:10.1038/s41388-018-0593-5.; Gavalas N.G., Liontos M., Trachana S.P., Bagratuni T., Arapinis C., Liacos C., Dimopoulos M.A., Bamias A. Angiogenesis-related pathways in the pathogenesis of ovarian cancer. Int J Mol Sci. 2013 Jul 30; 14(8): 15885–909. doi:10.3390/ijms140815885.; Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010 Sep; 177(3): 1053–64. doi:10.2353/ajpath.2010.100105.; Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989 Aug; 8(2): 98–101.; Yeung T.L., Leung C.S., Yip K.P., Au Yeung C.L., Wong S.T., Mok S.C. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol. 2015 Oct 1; 309(7): C444–56. doi:10.1152/ajpcell.00188.2015.; Li J., Chen H., Mariani A., Chen D., Klatt E., Podratz K., Drapkin R., Broaddus R., Dowdy S., Jiang S.W. HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines. Int J Mol Sci. 2013 Mar 15; 14(3): 6026–43. doi:10.3390/ijms14036026.; Zhu L., Zhuang H., Wang H., Tan M., Schwab C.L., Deng L., Gao J., Hao Y., Li X., Gao S., Liu J., Lin B. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer. Oncotarget. 2016 Jan 5; 7(1): 729–44. doi:10.18632/oncotarget.6327.; Hamed E.O., Ahmed H., Sedeek O.B., Mohammed A.M., AbdAlla A.A., Abdel Ghaffar H.M. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response. Diagn Pathol. 2013 Jan 23; 8: 11. doi:10.1186/1746-1596-8-11.; Karlsen M.A., Høgdall E.V., Christensen I.J., Borgfeldt C., Kalapotharakos G., Zdrazilova-Dubska L., Chovanec J., Lok C.A., Stiekema A., Mutz-Dehbalaie I., Rosenthal A.N., Moore E.K., Schodin B.A., Sumpaico W.W., Sundfeldt K., Kristjansdottir B., Zapardiel I., Høgdall C.K. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer – An international multicenter study in women with an ovarian mass. Gynecol Oncol. 2015; 138(3): 640–6. doi:10.1016/j.ygyno.2015.06.021.; Kong X., Chang X., Cheng H., Ma R., Ye X., Cui H. Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways. Int J Gynecol Cancer. 2014 Mar; 24(3): 427–36. doi:10.1097/IGC.0000000000000078.; Wang A., Jin C., Tian X., Wang Y., Li H. Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK/STAT3 pathway. Biol Open. 2019 Sep 2; 8(9): bio043570. doi:10.1242/bio.043570.; Ribeiro J.R., Gaudet H.M., Khan M., Schorl C., James N.E., Oliver M.T., DiSilvestro P.A., Moore R.G., Yano N. Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix. Front Oncol. 2018; 7: 332. doi:10.3389/fonc.2017.00332.; James N.E., Beffa L., Oliver M.T., Borgstadt A.D., Emerson J.B., Chichester C.O., Yano N., Freiman R.N., DiSilvestro P.A., Ribeiro J.R. Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes. Oncotarget. 2019 May 21; 10(36): 3315–3327.; Bowtell D.D., Böhm S., Ahmed A.A., Aspuria P.J., Bast R.C.Jr., Beral V., Berek J.S., Birrer M.J., Blagden S., Bookman M.A., Brenton J.D., Chiappinelli K.B., Martins F.C., Coukos G., Drapkin R., Edmondson R., Fotopoulou C., Gabra H., Galon J., Gourley C., Heong V., Huntsman D.G., Iwanicki M., Karlan B.Y., Kaye A., Lengyel E., Levine D.A., Lu K.H., McNeish I.A., Menon U., Narod S.A., Nelson B.H., Nephew K.P., Pharoah P., Powell D.J.Jr., Ramos P., Romero I.L., Scott C.L., Sood A.K., Stronach E.A., Balkwill F.R. Rethinking ovarian cancer II: reducing mortality from highgrade serous ovarian cancer. Nat Rev Cancer. 2015 Nov; 15(11): 668–79. doi:10.1038/nrc4019.; Miranda F., Mannion D., Liu S., Zheng Y., Mangala L.S., Redo-ndo C., Herrero-Gonzalez S., Xu R., Taylor C., Chedom D.F., Karaminejadranjbar M., Albukhari A., Jiang D., Pradeep S., Rodriguez-Aguayo C., Lopez-Berestein G., Salah E., Abdul Azeez K.R., Elkins J.M., Campo L., Myers K.A., Klotz D., Bivona S., Dhar S., Bast R.C.Jr., Saya H., Choi H.G., Gray N.S., Fischer R., Kessler B.M., Yau C., Sood A.K., Motohara T., Knapp S., Ahmed A.A. Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. Cancer Cell. 2016 Aug 8; 30(2): 273–289. doi:10.1016/j.ccell.2016.06.020.; Виллерт А.Б., Коломиец Л.А., Юнусова Н.В., Иванова А.А. Асцит как предмет исследований при раке яичников. Сибирский онкологический журнал. 2019; 18(1): 116–123. doi:10.21294/1814-4861-2019-18-1-116-123.; Кит О.И., Франциянц Е.М., Моисеенко Т.И., Вереникина Е.В., Черярина Н.Д., Козлова Л.С., Погорелова Ю.А. Факторы роста семейства VEGF и FGF в сыворотке крови в динамике развития рака яичников. Современные проблемы науки и образования. 2017; 1. URL: https://science-education.ru/ru/article/view?id=25898Test (дата обращения: 06.05.2020).; Weidle U.H., Birzele F., Kollmorgen G., Rueger R. Mechanisms and Targets Involved in Dissemination of Ovarian Cancer. Cancer Genomics Proteomics. 2016 11–12; 13(6): 407–423. doi:10.21873/cgp.20004.; Motohara T., Masuda K., Morotti M., Zheng Y., El-Sahhar S., Chong K.Y., Wietek N., Alsaadi A., Karaminejadranjbar M., Hu Z., Artibani M., Gonzalez L.S., Katabuchi H., Saya H., Ahmed A.A. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene. 2019 Apr; 38(16): 2885–98. doi:10.1038/s41388-018-0637-x.; Foley O.W., Rauh-Hain J.A., del Carmen M.G. Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park). 2013; 27: 288–94.; Gerber S.A., Rybalko V.Y., Bigelow C.E., Lugade A.A., Foster T.H., Frelinger J.G., Lord E.M. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol. 2006 Nov; 169(5): 1739–52. doi:10.2353/ajpath.2006.051222.; https://www.siboncoj.ru/jour/article/view/1988Test

الإتاحة: https://doi.org/10.21294/1814-4861-2021-20-6-69-77Test
https://doi.org/10.21294/1814-4861-2021-20-6Test
https://doi.org/10.3233/CBM-181229Test
https://doi.org/10.3389/fonc.2018.00124Test
https://doi.org/10.1038/nrc3144Test
https://doi.org/10.1038/s41388-018-0593-5Test
https://doi.org/10.3390/ijms140815885Test
https://doi.org/10.2353/ajpath.2010.100105Test
https://doi.org/10.1152/ajpcell.00188.2015Test
https://doi.org/10.3390/ijms14036026Test